Article info
Clinical and epidemiological research
Extended report
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
- Correspondence to Dr Theo Rispens, Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Plesmanlaan 125, Amsterdam 1066CX, The Netherlands; t.rispens{at}sanquin.nl
Citation
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
Publication history
- Received July 23, 2012
- Revised November 5, 2012
- Accepted December 2, 2012
- First published January 7, 2013.
Online issue publication
September 04, 2013
Article Versions
- Previous version (7 January 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions